PROTAGONIST THERAPEUTICS, INC. (PTGX) Operating cash flow 2016–2025
PROTAGONIST THERAPEUTICS, INC. (PTGX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$57.7MFY2025 · since FY2016: -$30.0M → $57.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $57.7M | -68.7% |
| FY2024 | $184.2M | +362.2% |
| FY2023 | -$70.2M | +35.0% |
| FY2022 | -$108.1M | -0.3% |
| FY2021 | -$107.9M | -48.8% |
| FY2020 | -$72.5M | -74.5% |
| FY2019 | -$41.5M | +16.9% |
| FY2018 | -$49.9M | -1390.0% |
| FY2017 | $3.9M | +112.9% |
| FY2016 | -$30.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice